Elite Wealth Management Inc. Takes $820,000 Position in HCA Healthcare, Inc. $HCA

Elite Wealth Management Inc. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 1,732 shares of the company’s stock, valued at approximately $820,000.

Other institutional investors also recently modified their holdings of the company. Palisade Asset Management LLC bought a new position in HCA Healthcare during the 3rd quarter valued at about $26,000. Ares Financial Consulting LLC purchased a new stake in HCA Healthcare in the fourth quarter worth approximately $31,000. Cedar Mountain Advisors LLC bought a new position in shares of HCA Healthcare during the 1st quarter valued at $33,000. JPL Wealth Management LLC bought a new stake in shares of HCA Healthcare in the third quarter worth $33,000. Finally, MCF Advisors LLC boosted its position in HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after purchasing an additional 49 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. HCA reported adjusted earnings of $7.59 per share versus the $7.56 consensus estimate, while revenue rose 8.7% year over year to $20.23 billion, topping forecasts of $19.76 billion. The earnings beat and continued revenue growth are supporting investor sentiment. HCA Healthcare’s Q2 CY2026 sales top estimates
• Positive Sentiment: Analysts remain broadly constructive despite lower targets. Truist, Oppenheimer and KeyCorp cut their price targets but retained buy, outperform or overweight ratings. RBC also reaffirmed its outperform rating with a $435 target, indicating that analysts still see upside from current levels. HCA Healthcare Analysts Slash Their Forecasts After Q2 Results
• Neutral Sentiment: HCA declared a quarterly dividend of $0.78 per share. The dividend is payable September 30 to shareholders of record September 16 and carries an indicated yield of approximately 0.8%, providing modest shareholder income.
• Neutral Sentiment: Leadership change at two Tampa hospitals. HCA promoted a new chief executive officer for the facilities, a routine management update with limited immediate financial impact. HCA promotes new CEO of 2 Tampa hospitals
• Negative Sentiment: Uninsured Affordable Care Act patients are a concern. Nearly all of HCA’s ACA exchange patients reportedly lacked insurance coverage during the quarter, highlighting reimbursement and bad-debt risks that could weigh on margins and future earnings.
• Negative Sentiment: Multiple analysts reduced their forecasts after the earnings release. Barclays moved to equal weight with a $387 target, while Baird maintained a neutral rating and lowered its target to $393. The widespread target reductions suggest expectations for HCA’s future growth and profitability have moderated.
• Negative Sentiment: Mission Health compliance concerns remain unresolved. Reports of a third consecutive year of compliance issues add legal, regulatory and reputational risk for HCA. HCA Healthcare faces third straight year of Mission Health compliance concerns

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. UBS Group lowered their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research note on Monday. Leerink Partners dropped their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. JPMorgan Chase & Co. cut their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Morgan Stanley lowered their price objective on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research report on Monday. Finally, Raymond James Financial set a $528.00 price target on HCA Healthcare in a report on Tuesday, July 7th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $473.36.

HCA Healthcare Trading Up 2.0%

Shares of HCA stock opened at $389.74 on Tuesday. The stock’s 50-day moving average price is $386.30 and its 200-day moving average price is $452.90. HCA Healthcare, Inc. has a 12-month low of $331.61 and a 12-month high of $556.52. The stock has a market capitalization of $86.46 billion, a price-to-earnings ratio of 13.05, a price-to-earnings-growth ratio of 1.29 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the previous year, the company posted $6.84 EPS. The company’s revenue was up 8.7% compared to the same quarter last year. As a group, research analysts predict that HCA Healthcare, Inc. will post 29.19 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.45%.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.